Innovative antibody research and development (R&D) is the vanguard of a variety of science, technology, and medical fields that require substantial investment of both time and money.
Reichert
Janice M
JM
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D035843:Biomedical Research / Q000191:economics*; D015195:Drug Design; D005380:Financing, Government; D006801:Humans; D009316:National Institutes of Health (U.S.); D017149:Private Sector; D012106:Research / Q000191:economics*; D012109:Research Support as Topic / Q000458:organization & administration / Q000706:statistics & numerical data; D014481:United States; D016270:United States Agency for Healthcare Research and Quality; D014483:United States Dept. of Health and Human Services / Q000458:organization & administration; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal